Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Lags Revenue Estimates
Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +6.45% and -82.80%, respectively, for the quarter ended September 2025. Do…
15,500$
-1,46%
Echtzeit-Aktienkurs Pulse Biosciences Inc.
Bid:
Ask:
Nachrichten zur Pulse Biosciences Inc. Aktie
Pulse Biosciences: Some Key Questions Remain Unanswered
…
Pulse Biosciences reports wider Q4 loss, shares dip By Investing.com
Pulse Biosciences reports wider Q4 loss, shares dip…
Pulse Biosciences director Robert Duggan buys $972,343 in stock By Investing.com
Pulse Biosciences director Robert Duggan buys $972,343 in stock…
Pulse Biosciences Inc. (PLSE) Q2 2024 Earnings Call Transcript
…
Pulse Biosciences announces updated timing of rights offering for up to $60M
…
Earnings call: Pulse Biosciences reports progress with CellFX system By Investing.com
Earnings call: Pulse Biosciences reports progress with CellFX system…
Pulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript
…
Earnings call: Pulse Biosciences advances with FDA clearances and trials By Investing.com
Earnings call: Pulse Biosciences advances with FDA clearances and trials…
Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript
…
Pulse Biosciences files for $50M mixed securities shelf
…